(4S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one
Zolmitriptan
CAS: 139264-17-8
Molecular Formula: C16H21N3O2
(4S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one - Names and Identifiers
| Name | Zolmitriptan |
| Synonyms | 139264-17-8 Zolmitriptan (S)-4-[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]methyl-2-oxazolidinone (4r)-4-[[3-(2-dimethylaminoethyl)-1h-indol-5-yl]methyl]oxazolidin-2-one 4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one (4R)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one (4S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one |
| CAS | 139264-17-8 |
| InChI | InChI=1/C16H21N3O2/c1-19(2)6-5-12-9-17-15-4-3-11(8-14(12)15)7-13-10-21-16(20)18-13/h3-4,8-9,13,17H,5-7,10H2,1-2H3,(H,18,20)/t13-/m1/s1 |
(4S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one - Physico-chemical Properties
| Molecular Formula | C16H21N3O2 |
| Density | 1.217±0.06 g/cm3(Predicted) |
| Melting Point | 136-141℃ |
| Boling Point | 563.3±38.0 °C(Predicted) |
| Flash Point | 294.5°C |
| Vapor Presure | 1.03E-12mmHg at 25°C |
| Appearance | White crystalline powder |
| pKa | 12.57±0.40(Predicted) |
| Storage Condition | 2-8℃ |
| Refractive Index | 1.619 |
| MDL | MFCD00871503 |
| Physical and Chemical Properties | Melting point 136-141°C |
(4S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one - Reference
| Reference Show more | 1. Ruan, Jiuheng, et al. "Investigation of effect of isopropyl palmitate on drug release from transdermal patch and molecular dynamics study." AAPS PharmSciTech 20.5 (2019): 1-12. 2. [IF=3.246] Ruan Jiuheng et al."Investigation of Effect of Isopropyl Palmitate on Drug Release from Transdermal Patch and Molecular Dynamics Study."Aaps Pharmscitech. 2019 Jul;20(5):1-12 |
(4S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one - Standard
Authoritative Data Verified Data
This product is (S)-4-[[3-[2-(dimethylamino) ethyl] indol-5-yl] methyl]-2-criazolidinone. Calculated as dried product, the content of C16H21N302 shall not be less than 99.0%.
Last Update：2024-01-02 23:10:35
(4S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one - Trait
Authoritative Data Verified Data
- This product is white or off-white crystalline powder; Odorless.
- This product is soluble in methanol, slightly soluble in acetone or acetonitrile, slightly soluble in water, slightly soluble in 0.lmol/L hydrochloric acid solution.
melting point
The melting point of this product (General 0612) is 135~140°C.
specific rotation
take this product, precision weighing, add methanol to dissolve and quantitative dilution to make a solution containing about 40mg per lml, according to the law (General 0621), the specific rotation was -4.0 ° to -6.0 °.
Last Update：2022-01-01 11:58:21
(4S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one - Differential diagnosis
Authoritative Data Verified Data
- Take 10 mg of this product, put it in a dry cold test tube, add 20mg malonic acid and 20 drops of acetic anhydride, put it in a boiling water bath and heat it for 1-3 minutes, and the solution will appear red-brown.
- Take appropriate amounts of the product and the reference product of zolmitriptan, add the mobile phase to dissolve and dilute according to the method under the item of determination of related substances to prepare a solution containing about 25mg of Zolmitriptan per 1 ml, 2ou1 was injected into the human liquid chromatograph, and the chromatogram was recorded. The retention time of the main peak of the test solution should be consistent with the retention time of the main peak of the reference solution.
- take this product, add 0.1 mol/L hydrochloric acid solution is dissolved and diluted to prepare a solution containing about 5pg per lm l, which is determined by UV-Vis spectrophotometry (General 0401), there is maximum absorption at 222nm and 283nm wavelengths and minimum absorption at 247nm wavelengths.
- The infrared absorption spectrum of this product should be consistent with that of the reference product (General rule 0402).
Last Update：2022-01-01 11:58:22
(4S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one - Exam
Authoritative Data Verified Data
Related substances
take this product, add mobile phase to dissolve and dilute to make a solution containing about 0.5mg per lml as a test solution; Take lml for precision measurement and put it in a 100ml measuring flask, the mobile phase was diluted to the scale and used as a control solution. According to the test of high performance liquid chromatography (General rule 0512), silica gel bonded with eighteen alkyl silane is used as the filler (Ultimate XB C18,4. 6mmx250mm, 5um or equivalent column); phosphate solution (6.8g of potassium dihydrogen phosphate, sodium heptanesulfonate 1.olg, dissolved in water and diluted to 6.0 ml, adjusted to pH with triethylamine)-acetonitrile (82:18) as mobile phase; The detection wavelength was 224mn. The number of theoretical plates shall not be less than 2000 calculated by Zolmitriptan peak, and the degree of separation between Zolmitriptan peak and adjacent impurity peaks shall meet the requirements. 20 u1 of the test solution and the control solution were respectively injected into the liquid chromatograph, and the chromatogram was recorded to 2 times of the retention time of the main component peak. If there are impurity peaks in the chromatogram of the test solution, the area of a single impurity peak shall not be greater than 0.5 times (0.5%) the area of the main peak of the control solution, and the sum of the areas of each impurity peak shall not be greater than the area of the main peak of the control solution (1.0%). The chromatogram of the test solution is 0.01 times smaller than the main peak area of the control solution, and the peak is negligible (0.01%).
R-isomer
measurement by capillary electrophoresis (General 0542).
electrophoresis conditions and system suitability test
an elastic quartz capillary column (inner diameter 5um) was used as the separation channel; with 30mmol/L hydroxypropyl-B-cyclodextrin solution (50mmol/L sodium dihydrogen phosphate buffer solution adjusted to pH 2.2 with phosphoric acid) as running buffer, the detection wavelength was 225nm, the separation voltage was 20kV, the injection end was positive, the column temperature was 25°C, and the pressure of 0.5psi was injected for 5 seconds. Pre-rinse with running buffer for 10 minutes prior to injection. Take the appropriate amount of Zolmitriptan reference and R-isomer reference, respectively, plus 0.1 mol/L hydrochloric acid solution is dissolved and diluted into a mixed solution containing 0.5mg of zolmitriptan and 2.5ug of isomer per 1 ml as the system suitability solution, and the sample is injected according to the above method, the number of theoretical plates shall not be less than 5000 calculated by Zolmitriptan peak, and the degree of separation between Zolmitriptan peak and isomer peak shall meet the requirements.
assay
take about 50mg of this product, put it in a 100ml measuring flask, add 0.1 mol/L hydrochloric acid solution dissolved and diluted to the scale, shake, as a test solution; Precision take 1ml, 200ml flask, with 0.1 mol/L hydrochloric acid solution was diluted to the scale and shaken to serve as a control solution. The test solution and the control solution were injected respectively, and the chromatograms were recorded. If there is a chromatographic peak in the chromatogram of the test solution that is consistent with the retention time of the isomer, the peak area shall not be greater than the main peak area of the control solution (0.5%).
residual solvent
methanol, isopropanol, dichloromethane, ethyl acetate, dioxane and toluene take about l. Add an appropriate amount of N,N-dimethylformamide, shake to dissolve, dilute to the scale, shake well, as a test solution; Accurately weigh methanol, isopropanol, dichloromethane, ethyl acetate, dioxane and toluene were Diluted quantitatively with N,N-dimethylformamide to prepare methanol 0.3mg, isopropanol 0.5mg, dichloromethane 0.06mg, A mixed solution of ethyl acetate 0.5mg, dioxane 0.038mg and toluene 0.089mg was used as a reference solution. According to the determination method of residual solvent (General Principle 0861 third method), the capillary column with 6% cyanopropyl phenyl-94% dimethyl polysiloxane (or similar polar) as stationary liquid is used as the column, and the initial temperature is 40°C, maintain 2 minutes, at a rate of 10°C per minute to 150°C, and then at a rate of 30°C per minute to 220°C, maintain 2 minutes; The temperature of the injection port is 200°C; hydrogen flame ionization detector (FID ), the detector temperature is 250°C; Take the reference solution into the sample, the separation degree between the peaks of each component should meet the requirements. The lul of the test solution and the reference solution are accurately measured and injected into the human gas chromatograph respectively. The chromatogram is recorded and the peak area is calculated according to the external standard method.
chloroform
take about 0.5g of this product, put it in a 10ml measuring flask, add an appropriate amount of N, N-dimethylformamide, shake to dissolve it, dilute it to the scale, and shake it well, as a test solution; Precision weighing the appropriate amount of chloroform, with N, N-dimethylformamide quantitative dilution made of chloroform containing about 0.003mg per 1 ml of the solution, as a reference solution. According to the determination method of residual solvent (General Principle 0861 third method), the capillary column with 6% cyanopropyl phenyl-94% dimethyl polysiloxane (or similar polar) as stationary liquid is used as the column, and the initial temperature is 50°C, maintain 1 minute, at a rate of 10°C per minute to 140°C, and then at a rate of 30°C per minute to 220°C, maintain 2 minutes; The temperature of the injection port is 220°C; electron capture detector (uECD), the temperature of the detector is 350 ℃; 1 u1 of the sample solution and the reference solution are accurately measured, and the human gas chromatograph is injected respectively to record the chromatogram, according to the external standard method to calculate the peak area, the residue should comply with the provisions.
loss on drying
take this product, dry to constant weight at 105°C, weight loss shall not exceed 0.5% (General rule 0831).
ignition residue
take this product, inspection according to law (General rule 0841), residual flooding shall not exceed 0.1%.
Heavy metals
The residue left under the item of taking the ignition residue shall not contain more than 10 parts per million of heavy metal when examined by law (General Principles 0821, Law II).
Last Update：2022-01-01 11:58:23
(4S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one - Content determination
Authoritative Data Verified Data
take this product about 0.25g, precision weighing, add glacial acetic acid 25ml and acetic anhydride 5ml to dissolve, add crystal violet indicator solution 1 drop, with perchloric acid titration solution (O. 1 mol/L) titration to a blue color of the solution, and the results of the titration were corrected by a blank test. Each 1 ml of perchloric acid titration solution (0.1 mol/L) corresponds to 28.74mg of C16H21N302.
Last Update：2022-01-01 11:58:24
(4S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one - Category
Authoritative Data Verified Data
anti-migraine.
Last Update：2022-01-01 11:58:24
(4S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one - Storage
Authoritative Data Verified Data
light shielding, sealed storage.
Last Update：2022-01-01 11:58:24
(4S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one - Zolmitriptan Tablets
Authoritative Data Verified Data
This product contains zolmitriptan (C16H21N302) should be the label amount of 90.0% ~ 110.0%.
trait
This product is white or white-like tablets or film-coated tablets, white or white-like after removing the coating.
identification
- take an appropriate amount of the fine powder of this product (about 10mg of Zolmitriptan), put it in a dry plug test tube, add 20mg malonic acid and 20 drops of acetic anhydride, and heat it in a boiling water bath for 1-3 minutes, the solution was red-brown in color.
- in the chromatogram recorded under the content determination item, the retention time of the main peak of the test solution should be consistent with the retention time of the main peak of the reference solution.
- take an appropriate amount of fine powder of this product and add 0.1 mol/L hydrochloric acid solution is dissolved and diluted to prepare a solution containing about 5ug of Zolmitriptan per 1 ml, filtered, and then the filtrate is taken and determined by UV-Vis spectrophotometry (General 0401), there is a maximum absorption at 222nm and 283nm wavelengths, and a minimum absorption at a wavelength of 247mn.
examination
- relevant substances: take an appropriate amount of the fine powder of this product, add the mobile phase to dissolve and dilute to prepare a solution containing about 0.5mg of Zolmitriptan per 1ml, filter, and take the continued filtrate as the test solution; take 1ml of precision, 100ml flask, diluted with mobile phase to scale, shake, as a control solution. The determination was carried out according to the method for the related substances of Zolmitriptan. If there are impurity peaks in the chromatogram of the test solution, the area of a single impurity peak shall not be greater than 0.5 times (0.5%) the area of the main peak of the control solution, and the sum of the areas of each impurity peak shall not be greater than the area of the main peak of the control solution (1.0%). The chromatogram of the test solution is 0.01 times smaller than the main peak area of the control solution, and the peak is negligible (0.01%).
- R-isomer take an appropriate amount of the fine powder of this product (approximately equivalent to 50mg of Zolmitriptan), put it in a 100ml measuring flask, add 0.1 mol/L hydrochloric acid solution dissolved and diluted to the scale, shake, filter, take the filtrate as a test solution; Precision take 1 ml, 200ml flask, with 0.1 mol/L hydrochloric acid solution was diluted to the scale and shaken to serve as a control solution. If there are chromatographic peaks with the same retention time as the R-isomer in the chromatogram of the test solution determined by the method under the R-isomer of zomitriptan, the peak area shall not be greater than the main peak area of the control solution (0.5%). The content uniformity shall be calculated based on the content of each tablet measured under the content determination item, and shall comply with the regulations (General rule 0941).
- dissolution of this product, according to the dissolution and release determination method (General 0931 first method), with 0.1 mol/L hydrochloric acid solution (100 ml) was used as dissolution medium, rotating at RPM, operated according to law. After 30 minutes, the solution was filtered, and the filtrate was continued as the test solution, the solution containing 5ug(2.5mg specification) or 10%(5mg specification) per 1 ml was prepared by precision weighing, dissolving and diluting with dissolution medium as a reference solution. According to the chromatographic conditions under the content determination item, take 10ul of each of the reference solution and the test solution, respectively inject the human liquid chromatograph, and record the chromatogram. The dissolution amount of each tablet was calculated by the peak area according to the external standard method. The limit is 80% of the labeled amount and shall be in accordance with the provisions.
- others shall be in accordance with the relevant provisions under the item of tablets (General rule 0101).
Content determination
- measured by high performance liquid chromatography (General 0512).
- chromatographic conditions and system suitability test using eighteen alkyl silane bonded silica gel as filler (Ultimate XB C18,4.6mm X 250mm, 5um or equivalent column), with phosphate solution (take potassium dihydrogen phosphate 6.8g, sodium heptane sulfonate l.Olg was dissolved in water and diluted to 6.0 ml, adjusted to pH with triethylamine-acetonitrile (82:18) as mobile phase; Detection wavelength was 224nm. The number of theoretical plates shall not be less than 2000 based on Zolmitriptan peak, Zolmitriptan peak and adjacent impurities
- the resolution between peaks shall meet the requirements.
- determination Method: Take 10 tablets of this product and put them in 100ml measuring flask (2.5mg specification) or 200m l measuring flask (5mg specification) respectively, and add appropriate amount of mobile phase, ultrasonic dissolution of zolmitriptan and dilution of the mobile phase to the scale, shake well, filter, take the filtrate as the test solution, and inject 20u1 into the liquid chromatograph to record the chromatogram •, an appropriate amount of Zolmitriptan reference substance was weighed accurately, dissolved and diluted with mobile phase to prepare a solution containing about 25ug per 1 ml, which was determined by the same method. According to the external standard method, the content of each tablet is calculated by the peak area, and the average content of 10 tablets is obtained.
category
Same as zolmitriptan.
specification
(1)2.5mg (2)5mg
storage
light shielding, sealed storage.
Last Update：2022-01-01 11:58:25
![(4S)-4-({3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}methyl)-1,3-oxazolidin-2-one](http://res.chembk.com/assets/images/structure/139264-17-8.gif)
Supplier List
Multiple SpecificationsSpot supply
Product Name: Zolmitriptan Visit Supplier Webpage Request for quotationCAS: 139264-17-8
Tel: 18301782025
Email: 3008007409@qq.com
Mobile: 18021002903
QQ: 3008007409
Wechat: 18301782025
Multiple SpecificationsSpot supply
Product Name: Zolmitriptan Visit Supplier Webpage Request for quotationCAS: 139264-17-8
Tel: 18301782025
Email: 3008007409@qq.com
Mobile: 18021002903
QQ: 3008007409
Wechat: 18301782025
View History